Coronavirus inhaler developed that fights killer bug at first sign of symptoms
INSUBCONTINENT EXCLUSIVE:
Synairgen, a Southampton-based drug development company, has started testing its inhaler in COVID-19 patients, and claims it can fight the
killer bug at the first sign of symptoms
